Announcements Talk on ‘How Pharma Companies Fudge Data’ on 23rd September 2019 in Mumbai   |   ESIC Medical College and PGIMSR, Chennai present Wissendurst’19 on 20 September 2019 with networking partner Forum for Medical Ethics Society and FMES’s Institute of Health Sciences   |   Citizenship, Governance and Accountability in Health – Join the COPASAH Conclave of Global Health Accountability and Human Rights Advocates: October 15-18, 2019 New Delhi, India   |   Open Letter: Stop the war on Syria’s hospitals

Cui bono?

Satyajit Rath

DOI: 10.20529/IJME.2008.052


Abstract

It feels odd reviewing a book that was published three years ago (and noted in IJME two years ago). Why is it worthwhile reviewing so long after publication a dryly written sociological monograph built around a case study of risk determination processes in early 20th-century clinical trials of polio vaccines? The answer lies in the accelerating industrialisation of clinical research, the elephant in the room that Halpern’s book continually skirts around, never quite addressing it directly, yet evidently aware of its presence as demonstrated by her last, almost ideological chapter. But let me start at the beginning.

Full Text

HTML PDF

Keywords

N/A

Refbacks

There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US